Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
G V Scagliotti, F De Marinis, M Rinaldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
G Masi, L Salvatore, L Boni, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
G Lelli, S Cataldo, I Carandina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont, A Figer, M Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2023
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
A de Gramont, A Figer, M Seymour, et al.
British Journal of Cancer
|
January 14, 2012
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)
C Boni, M Tiseo, L Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
F Di Costanzo, A Sobrero, S Gasperoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
E Van Cutsem, C Boni, J Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group
H Mouridsen, M Gershanovich, Y Sun, et al.
Journal of the National Cancer Institute
|
November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
U Veronesi, G De Palo, E Marubini, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
G V Scagliotti, F De Marinis, M Rinaldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
G Masi, L Salvatore, L Boni, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
G Lelli, S Cataldo, I Carandina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont, A Figer, M Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2023
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
A de Gramont, A Figer, M Seymour, et al.
British Journal of Cancer
|
January 14, 2012
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)
C Boni, M Tiseo, L Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
F Di Costanzo, A Sobrero, S Gasperoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
E Van Cutsem, C Boni, J Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group
H Mouridsen, M Gershanovich, Y Sun, et al.
Journal of the National Cancer Institute
|
November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
U Veronesi, G De Palo, E Marubini, et al.
Page
of 14